She has 17 years of experience in the design and implementation of genetic and genomic studies in the fields of neuropsychiatry, cardiovascular disease, pharmacogenomics, and oncology. In addition, Holly has 10 years of molecular genetics laboratory experience and a certification in clinical research. As a contractor for Booz Allen, she has supported the precisionFDA initiative for more than two years.